Dr. Means is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4488 Carothers Pkwy
Ste 300
Franklin, TN 37067Phone+1 615-591-4764Fax+1 615-591-7947
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2004
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1997 - 2000
- Brody School of Medicine at East Carolina UniversityClass of 1997
Certifications & Licensure
- TN State Medical License 2002 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 39 citationsPhase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.Anthony W. Tolcher, Razelle Kurzrock, V. Valero, V. Valero, Rene Gonzalez
Cancer Chemotherapy and Pharmacology. 2020-02-15 - 17 citationsA Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)Julie Means-Powell, Ingrid A. Mayer, Roohi Ismail-Khan, Luis Del Valle, Debra A. Tonetti
Clinical Breast Cancer. 2021-10-28 - 4 citationsComparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical stu...Donna C Ferguson, Daniel Jerad Long, Megan Christine Smith, Laura Deeanne Craig-Owens, Julie Means
Journal of Ovarian Research. 2015-06-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: